These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 22647855

  • 1. Rituximab-responsive nephrotic syndrome due to minimal change disease in systemic lupus erythematosus.
    Shahane A, Khasnis A, Gota C.
    J Clin Rheumatol; 2012 Jun; 18(4):199-202. PubMed ID: 22647855
    [No Abstract] [Full Text] [Related]

  • 2. [Beneficial effects of rituximab in the treatment of refractory nephrotic syndrome].
    Imai E.
    Nihon Jinzo Gakkai Shi; 2012 Jun; 54(5):593-7. PubMed ID: 22991838
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Rituximab: effective treatment for severe steroid-dependent minimal change nephrotic syndrome?
    Hofstra JM, Deegens JK, Wetzels JF.
    Nephrol Dial Transplant; 2007 Jul; 22(7):2100-2. PubMed ID: 17389619
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The administration of low doses of rituximab followed by hydroxychloroquine, prednisone and low doses of mycophenolate mofetil is an effective therapy in Latin American patients with active systemic lupus erythematosus.
    Galarza-Maldonado C, Kourilovitch MR, Molineros JE, Cardiel MH, Zurita L, Soroka NF, Yagur VY, Doukh N, Cervera R.
    Autoimmun Rev; 2010 Dec; 10(2):108-11. PubMed ID: 20804861
    [Abstract] [Full Text] [Related]

  • 7. Treatment of hemophagocytic lymphohistiocytosis with alemtuzumab in systemic lupus erythematosus.
    Keith MP, Pitchford C, Bernstein WB.
    J Clin Rheumatol; 2012 Apr; 18(3):134-7. PubMed ID: 22426581
    [Abstract] [Full Text] [Related]

  • 8. A case of minimal change disease treated successfully with mycophenolate mofetil in a patient with systemic lupus erythematosus.
    Hong YH, Yun DY, Jung YW, Oh MJ, Kim HJ, Lee CK.
    Korean J Intern Med; 2011 Dec; 26(4):470-3. PubMed ID: 22205851
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hydroxychloroquine in lupus pregnancy.
    Clowse ME, Magder L, Witter F, Petri M.
    Arthritis Rheum; 2006 Nov; 54(11):3640-7. PubMed ID: 17075810
    [Abstract] [Full Text] [Related]

  • 17. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
    Roccatello D, Sciascia S, Rossi D, Alpa M, Naretto C, Baldovino S, Menegatti E, La Grotta R, Modena V.
    Nephrol Dial Transplant; 2011 Dec; 26(12):3987-92. PubMed ID: 21385860
    [Abstract] [Full Text] [Related]

  • 18. Pneumocystis carinii pneumonia after discontinuation of hydroxychloroquine in 2 patients with systemic lupus erythematosus.
    Podrebarac TA, Jovaisas A, Karsh J.
    J Rheumatol; 1996 Jan; 23(1):199-200. PubMed ID: 8838542
    [No Abstract] [Full Text] [Related]

  • 19. Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy.
    Yang T, Nast CC, Vo A, Jordan SC.
    Nephrol Dial Transplant; 2008 Jan; 23(1):377-80. PubMed ID: 17981884
    [No Abstract] [Full Text] [Related]

  • 20. [Current therapy of nephrotic syndrome].
    Wegmüller E.
    Schweiz Med Wochenschr; 1984 Mar 17; 114(11):374-80. PubMed ID: 6710108
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.